TrialOne is the number one proactive eSource and Phase I site automation solution for early phase clinic operations.
Costa Mesa, Ca (PRWEB) November 20, 2013
WCCT Global, a contract research organization headquartered in Orange County, California, announced today the successful implementation of their paperless bedside data capture system in their early phase clinical trial units in California with the use of TrialOne. TrialOne is the number one proactive eSource and Phase I site automation solution for early phase clinic operations. The WCCTG process is an end to end solution that starts with their recruitment and enrollment division which extends into their clinics and wraps up with the Data Management team providing real-time study data access to their study sponsors. The data that is collected is entered within 48 hours of subject's visit to the site. The data is stored and categorized to allow sponsors to access patients based on indication. This web-based, tablet compatible system provides an advanced platform for automation and complies with FDA 21 CFR part 11 as well as supporting standards such as CDISC.
“We are thrilled and excited to now be able to offer such a cutting-edge solution to our sponsors,” exclaimed Audrey Hill, Director of Data Management at WCCTG. “I also wanted to point out the extensive validation and testing effort that went into the implementation of this system and to thank the internal WCCTG team—they are superstars!”
WCCT Global is raising the bar for the standard for a Full-Service CRO with the use of this data capture system not only for early phase clinical trials but for late phase trials as well. The company has made a commitment to giving their clients only cutting-edge options that improves overall timelines across all aspects of a clinical trial from recruitment to completion.
About WCCT Global:
WCCT Global is a multi-site, full-service global contract research organization (CRO) of outsourced early drug development and late phase services to the pharmaceutical, biotechnology and medical device industries. The WCCT Global vision, "With compassion for people, we strive for tomorrow’s therapies to be available today" truly exemplifies the focus and reason for our cutting-edge work both in our clinics and throughout our operations. As a drug development partner, WCCT Global collaborates with domestic and foreign innovator companies who need regulatory program management, data management and strategic consulting support, with an emphasis on overseeing and executing trials in special disease populations, pediatric populations, ethno-bridging, and cardiac safety. WCCT has extensive experience with healthy volunteer studies including First-in-Human (FIH), as well as specific therapeutic expertise in Allergy, Asthma, HCV, Ophthalmology, Oncology, Renal, and Vaccines.
If you are interested in how WCCT Global can service one of your upcoming clinical studies, CLICK HERE.